BridgeBio Pharma BBIO
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 76.49 | 113.09 | -0.99 | -139,562 | -214 | |
| 2025Q3 | 51.94 | 118.53 | -0.95 | -145,199 | -199 | |
| 2025Q2 | 43.18 | 108.44 | -0.96 | -134,278 | -202 | |
| 2025Q1 | 34.57 | 93.26 | -0.88 | -104,372 | -183 | |
| 2024Q4 | 27.44 | 102.87 | -1.42 | -226,027 | -282 | |
| 2024Q3 | 25.46 | 142.43 | -0.87 | -191,750 | -169 | |
| 2024Q2 | 25.33 | 392.86 | -0.39 | -175,539 | -81 | |
| 2024Q1 | 30.92 | -2.70 | -0.20 | 343 | -35 | |
| 2023Q4 | 40.37 | 118.23 | -0.96 | -177,416 | -168 | |
| 2023Q3 | 26.37 | 99.06 | -1.09 | -157,692 | -177 | |
| 2023Q2 | 17.20 | 104.28 | -0.98 | -146,099 | -158 | |
| 2023Q1 | 16.58 | 102.90 | -0.92 | -126,163 | -140 | |
| 2022Q4 | 7.62 | 107.18 | -0.92 | -129,232 | -138 | |
| 2022Q3 | 9.94 | 107.27 | -0.93 | -129,116 | -137 | |
| 2022Q2 | 9.08 | -452.46 | -0.06 | -80,176 | -10 | |
| 2022Q1 | 10.15 | 95.96 | -1.35 | -173,678 | -196 | |
| 2021Q4 | 16.68 | 120.76 | -1.02 | -165,614 | -147 | |
| 2021Q3 | 46.87 | 99.70 | -1.06 | -149,499 | -156 | |
| 2021Q2 | 60.96 | 103.05 | -0.64 | -94,015 | -96 | |
| 2021Q1 | 61.60 | 103.82 | -1.18 | -167,504 | -163 |